![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 22, 2010 11:49:11 AM
Kraig Biocraft Laboratories Announces That Raymond Kutsunai Has Joined Its Business Advisory Board
Renowned Former SmithKline & French Laboratories Executive Joins Kraig Advisory Board
LANSING, MI, Nov 22, 2010 (MARKETWIRE via COMTEX) -- Kraig Biocraft Laboratories, Inc. (pinksheets:KBLB) announced today that Raymond Kutsunai, the former general manager of SmithKline & French Laboratories, Japan, has joined the Company's Board of Advisors.
Mr. Kutsunai was a central figure in SmithKline & French Laboratories operations and spectacular growth in Japan. Kutsunai is the second former major executive from SmithKline to join Kraig Biocraft Laboratories' advisory board. Earlier this month SmithKline Beecham's celebrated former CEO and Chairman Henry Wendt joined the Company's Board of Advisors. SmithKline Beecham, which became Glaxo SmithKline, is one of the world's largest and most successful corporations.
"Kraig Biocraft Laboratories is privileged to be able to attract this extraordinary level of talent," said the Company's founder and CEO Kim K. Thompson. "We are particularly excited about bringing Mr. Kutsunai onto the team. He rightfully deserves his stellar reputation in Japan for accomplishment and integrity. In addition to his extensive business experience and leadership Mr. Kutsunai also has extensive contacts in Japan which may prove to be invaluable as our Company grows. His proven record for orchestrating and managing explosive growth is exactly what we need as we move to commercialize our technologies."
Kraig Biocraft Laboratories is a fully reporting biotechnology company, which recently achieved a series of scientific breakthroughs with implications for the global textile industry.
To learn more about Kraig Biocraft Laboratories and its recent commercial and scientific breakthroughs please visit www.KraigLabs.com. The website hosts several short videos describing the Company's recent commercial and technological breakthroughs and outlines the commercial potential that has garnered attention of many scientific and trade journals.
Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "hopes," "develops," "researching," "research," "potential," "implications," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM